FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

36527811000001104: Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Jan 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
112347701000001116 Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112347801000001113 Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Is a Product containing precisely carbocisteine 375 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has basis of strength substance Carbocisteine true Inferred relationship Existential restriction modifier 1
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has presentation strength numerator value 375 false Inferred relationship Existential restriction modifier 1
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has presentation strength denominator unit Capsule true Inferred relationship Existential restriction modifier 1
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has precise active ingredient Carbocisteine true Inferred relationship Existential restriction modifier 1
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has unit of presentation Capsule true Inferred relationship Existential restriction modifier
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has specific active ingredient Carbocisteine true Inferred relationship Existential restriction modifier
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) 120 capsule 12 x 10 capsules Has AMP True Carbocisteine 375mg capsules (Flamingo Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start